In vivo B-cell depletion with rituximab for alternative donor hemopoietic SCT

Emerging Role of CD20 Blockade in Allogeneic Hematopoietic Cell Transplantation

(2010) Mohamed A. Kharfan-Dabaja et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation

(2009) O. Landgren et al.   BLOOD

The role of B cells in the pathogenesis of graft-versus-host disease

(2009) A. Shimabukuro-Vornhagen et al.   BLOOD

Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation

(2009) A. M. Leen et al.   BLOOD

Prior rituximab correlates with less acute graft-versus-host disease and better survival in B-cell lymphoma patients who received allogeneic peripheral blood stem cell transplantation

(2009) Voravit Ratanatharathorn et al.   BRITISH JOURNAL OF HAEMATOLOGY

Epstein–Barr virus-associated lymphoproliferative disease after allogeneic haematopoietic stem cell transplantation: molecular monitoring and early treatment of high-risk patients

(2008) Ellen Meijer et al.   CURRENT OPINION IN HEMATOLOGY

T cell therapy of Epstein–Barr virus and adenovirus infections after hemopoietic stem cell transplant

(2007) P. Comoli et al.   BLOOD CELLS MOLECULES AND DISEASES